Intersecting established pharmacology with emerging medical technology, Entheon is developing a data-driven and comprehensive addiction recovery solution that personalizes patient care through all stages of treatment.

Despite the options available today, instances of addiction and related deaths continue to rise. Combining the clinical and nonclinical research of DMT with genetics and EEG biomarkers into a comprehensive treatment system will enable us to leverage empirical, objective evidence that is currently missing from available addiction treatments